TDS Pharm Co (XKRX:464280) Long-Term Debt : ₩0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Long-Term Debt?

TDS Pharm Co's Long-Term Debt for the quarter that ended in Dec. 2024 was ₩0 Mil.

TDS Pharm Co's quarterly Long-Term Debt declined from Mar. 2024 (₩475 Mil) to Sep. 2024 (₩0 Mil) but then stayed the same from Sep. 2024 (₩0 Mil) to Dec. 2024 (₩0 Mil).

TDS Pharm Co's annual Long-Term Debt increased from Dec. 2022 (₩675 Mil) to Dec. 2023 (₩775 Mil) but then declined from Dec. 2023 (₩775 Mil) to Dec. 2024 (₩0 Mil).

TDS Pharm Co Long-Term Debt Historical Data

The historical data trend for TDS Pharm Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Long-Term Debt Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

675.00

775.00

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial				-	775.00	475.00	-	-

TDS Pharm Co (XKRX:464280) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

TDS Pharm Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines